\-\ Texto\\:\\ \ \(0\)\
\-\ none\ \(204\)\
\-\ orchiectomy\ \(25\)\
\-\ sonographic\\ longitudinal\\ images\\ of\\ the\\ left\\ testis\\ \\ demonstrates\\ a\\ hypoechoic\\ 4mm\\ nodule\\.\\ additionally\\,\\ several\\ \\(less\\ than\\ 5\\)\\ punctate\\ hyperechoic\\ foci\\ are\\ present\\ consistent\\ with\\ limited\\ microlithiasis\\.\ \(0\)\
\-\ testicular\\ microlithiasis\ \(11\)\
\-\ testicular\\ seminoma\ \(2\)\
\-\ nodule\\:\ \(1\)\
\-\ 1\\.\\ testicular\\ neoplasm\ \(0\)\
\-\ 2\\.\\ hematoma\ \(0\)\
\-\ 3\\.\\ trauma\\ \ \(0\)\
\-\ 4\\.\\ infection\ \(0\)\
\-\ punctate\\ hyperechoic\\ foci\\:\\ limited\\ microlithiasis\\ \ \(0\)\
\-\ causes\\:\ \(5\)\
\-\ 1\\.\\ granulomatous\\ changes\ \(2\)\
\-\ 2\\.\\ scar\ \(2\)\
\-\ 3\\.\\ benign\\ adenomatoid\\ tumor\ \(2\)\
\-\ 4\\.\\ hemorrhage\ \(2\)\
\-\ 5\\.\\ post\\-inflammatory\\ changes\ \(2\)\
\-\ 27\\ year\\ old\\ man\\ status\\ post\\ trauma\\ with\\ pain\\ in\\ testicles\\.\\ ultrasound\\ requested\\ to\\ evaluate\\ source\\ of\\ pain\\ and\\ possible\\ trauma\\.\ \(0\)\
\-\ classic\\ testicular\\ microlithiasis\\ is\\ defined\\ as\\ greater\\ than\\ 5\\ hyperechoic\\ nonshadowing\\ foci\\ \\(in\\ one\\ image\\)\\ throughout\\ the\\ parenchyma\\ of\\ the\\ testes\\.\\ although\\ frequently\\ symmetric\\,\\ it\\ can\\ often\\ times\\ be\\ asymptomatic\\ and\\ seen\\ on\\ the\\ periphery\\ of\\ the\\ testis\\.\\ in\\ patients\\ where\\ less\\ than\\ 5\\ foci\\ are\\ present\\ per\\ image\\,\\ limited\\ microlithiasis\\ is\\ diagnosed\\.\\ \ \(0\)\
\-\ previously\\ it\\ was\\ thought\\ that\\ germ\\ cell\\ tumors\\ were\\ present\\ in\\ up\\ to\\ 40\\%\\ of\\ patients\\ with\\ microlithiasis\\ \\(ref\\ 1\\ and\\ 2\\)\\.\\ this\\ corresponded\\ to\\ approximately\\ 21\\ times\\ increased\\ risk\\ of\\ testicular\\ cancer\\.\\ due\\ to\\ these\\ limited\\ studies\\,\\ there\\ were\\ controversial\\ recommendations\\ to\\ perform\\ yearly\\ ultrasound\\ follow\\-up\\ examinations\\ in\\ these\\ patients\\.\\ these\\ studies\\ were\\ performed\\ with\\ small\\ patient\\ numbers\\ in\\ individuals\\ referred\\ for\\ ultrasound\\ due\\ to\\ identification\\ of\\ testicular\\ masses\\.\ \(0\)\
\-\ more\\ recent\\ studies\\ \\(ref\\ 3\\ and\\ 4\\)\\ were\\ performed\\ with\\ much\\ larger\\ study\\ subjects\\ involving\\ all\\ patients\\ undergoing\\ testicular\\ ultrasound\\ for\\ any\\ reason\\.\\ they\\ have\\ demonstrated\\ less\\ risk\\ \\(8\\%\\)\\ of\\ testicular\\ neoplasms\\ in\\ patients\\ with\\ microlithiasis\\ than\\ previously\\ thought\\.\\ moreover\\,\\ with\\ an\\ average\\ follow\\-up\\ ultrasound\\ average\\ of\\ 42\\ months\\,\\ no\\ additional\\ tumors\\ were\\ identified\\ in\\ these\\ patients\\ \\(ref\\ 4\\)\\.\\ the\\ authors\\ of\\ these\\ studies\\ suggested\\ that\\ it\\ would\\ not\\ significantly\\ affect\\ mortality\\/morbidity\\ to\\ continue\\ annual\\ ultrasound\\ surveillance\\.\\ they\\ suggested\\ a\\ more\\ reasonable\\ approach\\ to\\ patients\\ with\\ limited\\/classic\\ microlithiasis\\ would\\ be\\ to\\ perform\\ annual\\ physical\\ exams\\ and\\ montly\\ self\\-exams\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ backus\\,\\ et\\.al\\.\\,\\ radiology\\ 1994\\;\\ 192\\:781\\-785\\.\\ \\(42\\ patients\\)\ \(0\)\
\-\ 2\\.\\ miller\\,\\ et\\.al\\.\\,\\ j\\ clin\\ ultrasound\\ 1996\\;\\ 24\\:197\\-202\\.\ \(0\)\
\-\ 3\\.\\ bennett\\,\\ et\\ al\\.\\,\\ testicular\\ microlithiasis\\:\\ us\\ follow\\-up\ \(0\)\
\-\ radiology\\.\\ 2001\\;218\\:359\\-363\\.\\ \ \(0\)\
\-\ 4\\.\\ middleton\\,\\ et\\ al\\.\\,testicular\\ microlithiasis\\:\\ prospective\\ analysis\\ of\\ prevalence\\ and\\ associated\\ tumor\ \(0\)\
\-\ radiology\\ 2002\\;224\\:425\\-428\\.\\ \\(1079\\ patients\\,\\ 195\\ with\\ testicular\\ microlithiasis\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ microlithiasis\\:\\ 0\\.5276805197584628\ \(0\)\
\-\ testicular\\:\\ 0\\.4008138790387052\ \(0\)\
\-\ patients\\:\\ 0\\.19671177196821268\ \(0\)\
\-\ ultrasound\\:\\ 0\\.1677561943770555\ \(0\)\
\-\ limited\\:\\ 0\\.15505340154349004\ \(0\)\
\-\ ref\\:\\ 0\\.14267411188903134\ \(0\)\
\-\ foci\\:\\ 0\\.1270232107989374\ \(0\)\
\-\ et\\:\\ 0\\.12174282873919937\ \(0\)\
\-\ studies\\:\\ 0\\.1140026035550128\ \(0\)\
\-\ these\\:\\ 0\\.10970104426922607\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.10730142697382515\ \(0\)\
\-\ were\\:\\ 0\\.10013765598602531\ \(0\)\
\-\ radiology\\:\\ 0\\.09335215036891016\ \(0\)\
\-\ than\\:\\ 0\\.08809834670820449\ \(0\)\
\-\ to\\:\\ 0\\.08741826789038036\ \(0\)\
\-\ testis\\:\\ 0\\.08415878215314494\ \(0\)\
\-\ of\\:\\ 0\\.08363667894555926\ \(0\)\
\-\ punctate\\:\\ 0\\.08097644407216036\ \(0\)\
\-\ average\\:\\ 0\\.08097644407216036\ \(0\)\
\-\ perform\\:\\ 0\\.08015060598149104\ \(0\)\
\-\ less\\:\\ 0\\.07929673858161726\ \(0\)\
\-\ exams\\:\\ 0\\.07887657937544718\ \(0\)\
\-\ in\\:\\ 0\\.07732266253944299\ \(0\)\
\-\ up\\:\\ 0\\.07687620062647577\ \(0\)\
\-\ suggested\\:\\ 0\\.07271956725035529\ \(0\)\
\-\ annual\\:\\ 0\\.0718210774857422\ \(0\)\
\-\ times\\:\\ 0\\.06992982569565453\ \(0\)\
\-\ 42\\:\\ 0\\.06907434198594019\ \(0\)\
\-\ with\\:\\ 0\\.06847089696106341\ \(0\)\
\-\ trauma\\:\\ 0\\.06769278929528048\ \(0\)\
\-\ thought\\:\\ 0\\.06709344884523524\ \(0\)\
\-\ previously\\:\\ 0\\.06237891806279861\ \(0\)\
\-\ nodule\\:\\ 0\\.061333226614653256\ \(0\)\
\-\ present\\:\\ 0\\.05981000663148996\ \(0\)\
\-\ it\\:\\ 0\\.059664721464781044\ \(0\)\
\-\ backus\\:\\ 0\\.05937254088196737\ \(0\)\
\-\ 1079\\:\\ 0\\.05937254088196737\ \(0\)\
\-\ classic\\:\\ 0\\.0581201671014117\ \(0\)\
\-\ montly\\:\\ 0\\.05741311576462202\ \(0\)\
\-\ tumors\\:\\ 0\\.05714856976939466\ \(0\)\
\-\ risk\\:\\ 0\\.055522192618706695\ \(0\)\
\-\ they\\:\\ 0\\.055522192618706695\ \(0\)\
\-\ would\\:\\ 0\\.055006465793644856\ \(0\)\
\-\ subjects\\:\\ 0\\.05465146117049557\ \(0\)\
\-\ nonshadowing\\:\\ 0\\.05360152882213898\ \(0\)\
\-\ corresponded\\:\\ 0\\.05269203605315023\ \(0\)\
\-\ middleton\\:\\ 0\\.05269203605315023\ \(0\)\
\-\ 195\\:\\ 0\\.05269203605315023\ \(0\)\
\-\ numbers\\:\\ 0\\.05117218785582474\ \(0\)\
\-\ bennett\\:\\ 0\\.05117218785582474\ \(0\)\
\-\ moreover\\:\\ 0\\.05052302275959304\ \(0\)\
\-\ image\\:\\ 0\\.049695675058812956\ \(0\)\
\-\ miller\\:\\ 0\\.04888044911066718\ \(0\)\
\-\ and\\:\\ 0\\.048170817958854396\ \(0\)\
\-\ changes\\:\\ 0\\.04696210742526081\ \(0\)\
\-\ the\\:\\ 0\\.046515330856799555\ \(0\)\
\-\ testicles\\:\\ 0\\.04645110814435294\ \(0\)\
\-\ performed\\:\\ 0\\.045970968108946866\ \(0\)\
\-\ yearly\\:\\ 0\\.04580194304812124\ \(0\)\
\-\ authors\\:\\ 0\\.04549917861323918\ \(0\)\
\-\ recommendations\\:\\ 0\\.04520930174755197\ \(0\)\
\-\ reasonable\\:\\ 0\\.044931259947027444\ \(0\)\
\-\ prospective\\:\\ 0\\.044931259947027444\ \(0\)\
\-\ due\\:\\ 0\\.04466671395180008\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.04440707227077086\ \(0\)\
\-\ 4mm\\:\\ 0\\.04440707227077086\ \(0\)\
\-\ adenomatoid\\:\\ 0\\.04440707227077086\ \(0\)\
\-\ controversial\\:\\ 0\\.04440707227077086\ \(0\)\
\-\ 1994\\:\\ 0\\.04415936939919538\ \(0\)\
\-\ reason\\:\\ 0\\.043249876630206636\ \(0\)\
\-\ testes\\:\\ 0\\.04304028845399478\ \(0\)\
\-\ identification\\:\\ 0\\.04304028845399478\ \(0\)\
\-\ more\\:\\ 0\\.04266876112624211\ \(0\)\
\-\ seminoma\\:\\ 0\\.04263952120186989\ \(0\)\
\-\ examinations\\:\\ 0\\.04244764715342552\ \(0\)\
\-\ surveillance\\:\\ 0\\.04244764715342552\ \(0\)\
\-\ prevalence\\:\\ 0\\.04244764715342552\ \(0\)\
\-\ post\\:\\ 0\\.042282171824509454\ \(0\)\
\-\ 1996\\:\\ 0\\.04207939107657247\ \(0\)\
\-\ clin\\:\\ 0\\.04077809890176738\ \(0\)\
\-\ tumor\\:\\ 0\\.040644609193477885\ \(0\)\
\-\ requested\\:\\ 0\\.0406316184543429\ \(0\)\
\-\ individuals\\:\\ 0\\.0406316184543429\ \(0\)\
\-\ affect\\:\\ 0\\.04021018023555565\ \(0\)\
\-\ periphery\\:\\ 0\\.03919927996128147\ \(0\)\
\-\ continue\\:\\ 0\\.038115877873400185\ \(0\)\
\-\ approach\\:\\ 0\\.03726927639416639\ \(0\)\
\-\ 2002\\:\\ 0\\.03718139029365525\ \(0\)\
\-\ source\\:\\ 0\\.03700894872140934\ \(0\)\
\-\ longitudinal\\:\\ 0\\.0369243379651726\ \(0\)\
\-\ scar\\:\\ 0\\.03667663509359713\ \(0\)\
\-\ 2001\\:\\ 0\\.03667663509359713\ \(0\)\
\-\ significantly\\:\\ 0\\.03651636703359526\ \(0\)\
\-\ germ\\:\\ 0\\.036282821469730504\ \(0\)\
\-\ neoplasms\\:\\ 0\\.03620671924462823\ \(0\)\
\-\ analysis\\:\\ 0\\.03613145794529865\ \(0\)\
\-\ undergoing\\:\\ 0\\.035287773207935455\ \(0\)\
\-\ sonographic\\:\\ 0\\.03496491284782727\ \(0\)\
\-\ larger\\:\\ 0\\.03477829628963806\ \(0\)\
\-\ granulomatous\\:\\ 0\\.034537170992970094\ \(0\)\
\-\ that\\:\\ 0\\.03372137601638122\ \(0\)\
\-\ much\\:\\ 0\\.03364992455280809\ \(0\)\
\-\ symmetric\\:\\ 0\\.03329536459616913\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.03319736177892629\ \(0\)\
\-\ per\\:\\ 0\\.03224543224781253\ \(0\)\
\-\ additionally\\:\\ 0\\.03199621865685915\ \(0\)\
\-\ frequently\\:\\ 0\\.03199621865685915\ \(0\)\
\-\ parenchyma\\:\\ 0\\.03156174175825871\ \(0\)\
\-\ be\\:\\ 0\\.03152211122320062\ \(0\)\
\-\ 27\\:\\ 0\\.031485639533156425\ \(0\)\
\-\ 21\\:\\ 0\\.03104606261313658\ \(0\)\
\-\ references\\:\\ 0\\.030975480859362012\ \(0\)\
\-\ us\\:\\ 0\\.030905623033768738\ \(0\)\
\-\ where\\:\\ 0\\.030533710002042677\ \(0\)\
\-\ evaluate\\:\\ 0\\.030212373134523067\ \(0\)\
\-\ additional\\:\\ 0\\.030118855716380354\ \(0\)\
\-\ are\\:\\ 0\\.02948579336937536\ \(0\)\
\-\ causes\\:\\ 0\\.029358031098338077\ \(0\)\
\-\ referred\\:\\ 0\\.028749257985791324\ \(0\)\
\-\ greater\\:\\ 0\\.02862382021785298\ \(0\)\
\-\ throughout\\:\\ 0\\.02857428488469733\ \(0\)\
\-\ 40\\:\\ 0\\.02857428488469733\ \(0\)\
\-\ diagnosed\\:\\ 0\\.02814396843964228\ \(0\)\
\-\ pain\\:\\ 0\\.027805972573381268\ \(0\)\
\-\ defined\\:\\ 0\\.027717435401593212\ \(0\)\
\-\ identified\\:\\ 0\\.02754553786691199\ \(0\)\
\-\ involving\\:\\ 0\\.02721423470988086\ \(0\)\
\-\ hematoma\\:\\ 0\\.027194053722413174\ \(0\)\
\-\ status\\:\\ 0\\.027113922465375962\ \(0\)\
\-\ benign\\:\\ 0\\.026689298522355055\ \(0\)\
\-\ neoplasm\\:\\ 0\\.02652294098650064\ \(0\)\
\-\ although\\:\\ 0\\.026450288795912942\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.026450288795912942\ \(0\)\
\-\ masses\\:\\ 0\\.026450288795912942\ \(0\)\
\-\ possible\\:\\ 0\\.026324982901664785\ \(0\)\
\-\ recent\\:\\ 0\\.026307268773897306\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.026012970565447\ \(0\)\
\-\ study\\:\\ 0\\.02591206385633013\ \(0\)\
\-\ cancer\\:\\ 0\\.025878757783667244\ \(0\)\
\-\ several\\:\\ 0\\.02549129342305127\ \(0\)\
\-\ often\\:\\ 0\\.025351494434164724\ \(0\)\
\-\ any\\:\\ 0\\.025109834379549015\ \(0\)\
\-\ approximately\\:\\ 0\\.02479095971839599\ \(0\)\
\-\ demonstrated\\:\\ 0\\.023877927807583063\ \(0\)\
\-\ for\\:\\ 0\\.0235520126888038\ \(0\)\
\-\ infection\\:\\ 0\\.023469380910651913\ \(0\)\
\-\ all\\:\\ 0\\.023128187127360953\ \(0\)\
\-\ months\\:\\ 0\\.022615512988743796\ \(0\)\
\-\ one\\:\\ 0\\.022245091227202432\ \(0\)\
\-\ cell\\:\\ 0\\.022225630990285933\ \(0\)\
\-\ is\\:\\ 0\\.02128024416506542\ \(0\)\
\-\ none\\:\\ 0\\.021232847081116592\ \(0\)\
\-\ consistent\\:\\ 0\\.02106691735771931\ \(0\)\
\-\ physical\\:\\ 0\\.02106691735771931\ \(0\)\
\-\ increased\\:\\ 0\\.021009783951397815\ \(0\)\
\-\ man\\:\\ 0\\.020569191134845784\ \(0\)\
\-\ associated\\:\\ 0\\.020478375412246636\ \(0\)\
\-\ can\\:\\ 0\\.020388754668077217\ \(0\)\
\-\ small\\:\\ 0\\.020041618230742485\ \(0\)\
\-\ demonstrates\\:\\ 0\\.019519258786489194\ \(0\)\
\-\ have\\:\\ 0\\.019409139097390303\ \(0\)\
\-\ seen\\:\\ 0\\.018291616038355548\ \(0\)\
\-\ images\\:\\ 0\\.01797203850294455\ \(0\)\
\-\ as\\:\\ 0\\.01560857629265905\ \(0\)\
\-\ there\\:\\ 0\\.015459435909503133\ \(0\)\
\-\ not\\:\\ 0\\.01533818838218541\ \(0\)\
\-\ an\\:\\ 0\\.014857206603426721\ \(0\)\
\-\ was\\:\\ 0\\.013540609431857687\ \(0\)\
\-\ this\\:\\ 0\\.01335054539625612\ \(0\)\
\-\ left\\:\\ 0\\.013253560922655264\ \(0\)\
\-\ patient\\:\\ 0\\.012636887756537186\ \(0\)\
\-\ no\\:\\ 0\\.012634510831617799\ \(0\)\
\-\ year\\:\\ 0\\.011973689210894313\ \(0\)\
\-\ on\\:\\ 0\\.011734233270882959\ \(0\)\
\-\ old\\:\\ 0\\.011498886437838517\ \(0\)\
